Prognia
Drug Database
🇪🇺EU · EMAWithdrawn

BTVPUR AlSap 2-4(bluetongue-virus serotype-2 antigen;bluetongue-virus serotype-4 antigen)

Marketing Authorisation Holder: Mérial

EMA Authorisation: 04/11/2010

INN: inactivated adjuvanted vaccine against bluetongue virus serotype 2 and 4 infections

Indication

Active immunisation of sheep to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotypes 2 and 4.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about BTVPUR AlSap 2-4 — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.